BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7907040)

  • 41. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal cervical cytology in sexually active adolescents.
    Russo JF; Jones DE
    J Adolesc Health Care; 1984 Oct; 5(4):269-71. PubMed ID: 6490482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient Department of Gynaecology of a Tertiary Care Centre.
    Sapkota RP; Pokhrel S; Bhandari A; Adhikari P; Shrestha M
    JNMA J Nepal Med Assoc; 2023 Sep; 61(265):699-702. PubMed ID: 38289804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paired Papanicolaou smears in the evaluation of atypical squamous cells.
    Andrews S; Hernandez E; Miyazawa K
    Obstet Gynecol; 1989 May; 73(5 Pt 1):747-50. PubMed ID: 2704501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET study. Harrisburg Area Research Network.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1992 Sep; 35(3):271-7. PubMed ID: 1517723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of concurrent Papanicolaou smear at time of cervical biopsy.
    Panos JC; Jones BA; Mazzara PF
    Diagn Cytopathol; 2001 Oct; 25(4):270-3. PubMed ID: 11599115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is cervicography a useful diagnostic test? A systematic overview of the literature.
    Nuovo J; Melnikow J; Hutchison B; Paliescheskey M
    J Am Board Fam Pract; 1997; 10(6):390-7. PubMed ID: 9407479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
    Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
    Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The value of screening using cervicography in dysplasia and neoplasms of the uterine cervix].
    Coibion M; Guenier C; Miloiu A; Andry M; Bonnal JL; Nogaret JM
    Rev Med Brux; 1990; 11(1-2):16-20. PubMed ID: 2406832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of cervical cytology in HIV-infected women.
    Del Priore G; Maag T; Bhattacharya M; Garcia PM; Till M; Lurain JR
    Gynecol Oncol; 1995 Mar; 56(3):395-8. PubMed ID: 7705674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pap smears in adolescents: to screen or not to screen?
    Kahn JA; Emans SJ
    Pediatrics; 1999 Mar; 103(3):673-4. PubMed ID: 10049976
    [No Abstract]   [Full Text] [Related]  

  • 55. Cervical cytology and the evaluation of the abnormal Papanicolaou smear.
    Noller KL
    Prim Care; 1988 Sep; 15(3):461-71. PubMed ID: 3054958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pap smear screening and changes in cervical cancer mortality in Sweden.
    Mählck CG; Jonsson H; Lenner P
    Int J Gynaecol Obstet; 1994 Mar; 44(3):267-72. PubMed ID: 7909766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
    Reed BD
    Arch Fam Med; 1996; 5(10):582-4. PubMed ID: 8930230
    [No Abstract]   [Full Text] [Related]  

  • 59. Preliminary comparison of papanicolaou smear and speculoscopy for assessing cervical cancer precursor lesions in pregnant adolescents.
    Shulman LP; Klett CC; Phillips OP
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):78-82. PubMed ID: 10326192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
    Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
    Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.